Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Addictive behaviors

ISSN 1873-6327

9 papers in the library · 49 citations · publishing 2007-2026

Papers

Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.

Addictive behaviors September 1, 2022 Kevin H. Yang, Benjamin H Han, Joseph J Palamar 30 citations

LSD use was linked with a higher likelihood of major depressive episodes and suicidal thinking, while salvia divinorum use was associated with increased suicidal thinking and DMT/AMT/Foxy use with suicidal planning. In contrast, ecstasy (MDMA) use was linked with a lower likelihood of serious psychological distress, major depressive episodes, and suicidal thinking. These findings from a large US national survey indicate that different hallucinogens have distinct associations with depression and suicidality, highlighting the need for further research on risks and consequences of nonmedical hallucinogen use.

Correlates of Salvia divinorum use in a national sample: findings from the 2009 National Survey on Drug Use and Health.

Addictive behaviors November 1, 2011 Jason A Ford, William C Watkins, Lindsey Blumenstein 19 citations

Using data from the 2009 National Survey on Drug Use and Health, which included nearly 70,000 respondents aged 12 and older across all 50 U.S. states and the District of Columbia, lifetime salvia use was reported by 1.66% of adolescents (ages 12–17) and 5.08% of adults (ages 18–34). Among adolescents, use correlated with age, gender, income, peer and parent attitudes toward substance use, and other drug use. Among adults, correlates included age, gender, race, religiosity, marital status, criminal involvement, and other substance use.

Lifetime psychedelic use and opioid use disorder severity in a National Survey: the roles of psychedelic type and mental health.

Addictive behaviors June 1, 2026 Sebastian Ehmann, Nathan M. Hager, Paul S. Regier et al.

Using data from the 2023 U.S. National Survey on Drug Use and Health, lifetime use of mescaline or peyote was associated with lower opioid use disorder severity, while lifetime use of LSD, psilocybin, MDMA, or DMT was associated with higher severity. The link between mescaline/peyote use and lower severity appeared only among adults with high mental health impairment. The findings suggest that different types of psychedelic use have divergent relationships with opioid use disorder severity, and that mental health status may influence these associations.

Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US.

Addictive behaviors November 1, 2025 Samantha M Ross-Cypcar, Justin A Haegele, Jeanette M Garcia

Among disabled adults, past-year hallucinogen use is more common (8.37%) than among nondisabled adults (4.86%). Of disabled adults who used hallucinogens, nearly half reported a major depressive episode, over two-thirds reported serious psychological distress, and about 40% reported suicidal thinking, planning, or attempt. About 4% said hallucinogen use worsened or caused emotional or mental health problems. The findings come from a nationally representative sample of adults aged 18–50.

Experimental and observational evidence on substance use and metacognition among adults: a systematic review.

Addictive behaviors August 1, 2026 Sarret Seng, Chizimuzo T C Okoli, Lovoria B Williams et al.

A systematic review of 36 studies (N = 2,852 participants) finds that substance use is generally associated with poorer metacognitive functioning, though effects vary by substance and study design. Experimental evidence shows alcohol's effects are mixed; cannabinoids generally impair metacognitive accuracy and calibration; benzodiazepines impair awareness of performance and error detection; methamphetamine has dose-dependent effects on agency judgments; and nicotine replacement does not restore accuracy after abstinence. Craving states are linked to poorer monitoring and calibration. Observational studies report that cocaine, nicotine, opioid, cannabis, alcohol, and polysubstance use are associated with greater maladaptive metacognitive beliefs and reduced monitoring accuracy, though some clinical comparisons show domain-specific or relatively preserved functioning.

Working memory capacity predicts cannabis-induced effects on alcohol urge.

Addictive behaviors March 1, 2026 Rachel L Gunn, Lindy K Howe, Holly K Boyle et al.

In a randomized placebo-controlled crossover trial, 125 adults who drank heavily and used cannabis at least twice weekly smoked placebo, 3.1% THC, or 7.2% THC cannabis cigarettes. Participants with higher working memory capacity, measured by a symmetry span task, reported significantly lower alcohol urge after smoking the higher THC dose compared to placebo. Lower working memory, measured by an n-back task, was linked to higher alcohol urge overall but did not alter cannabis's effect on urge. The authors suggest that individuals with lower working memory may be less likely to experience reduced alcohol craving from cannabis.

Sip, savor, but don't spill: mindfulness enhances alcohol enjoyment without boosting consumption.

Addictive behaviors January 1, 2026 Ran Ma, Xingzhe Wu, Wei Xu

Brief mindfulness meditation can increase the enjoyment of alcohol in healthy young adults who are not addicted, without increasing how much they actually drink. Across two randomized trials with 67 and 89 participants respectively, a 16-minute mindfulness induction led to significantly higher subjective alcohol enjoyment and greater positive affect, along with reduced negative emotion, compared to a neutral control task. However, mindfulness did not change the amount of alcohol consumed, nor did it alter implicit attitudes toward alcohol versus tea. The findings suggest that mindfulness may intensify sensory and emotional responses to alcohol without boosting consumption, possibly because reward sensitivity and behavioral impulse are dissociated. This highlights the need to align mindfulness practices with specific motivational and regulatory goals to avoid unintended reinforcement of substance-related pleasure in non-addicted populations.

Development and initial validation of an MDMA/Ecstasy motives assessment.

Addictive behaviors January 1, 2023 James E Sottile, Kathryn S Macia, Robert E Wickham et al.

MDMA/Ecstasy users are motivated by social, expansion, coping, and energy factors, distinct from the motives for alcohol, cannabis, or methamphetamine use. A new four-factor motives scale was developed from an international online sample of 1,754 adults. The scale showed good internal consistency and validity, with social, expansion, coping, and energy motives emerging as significant, while conformity and enhancement did not. The findings highlight the unique stimulating, emotional, and empathic effects sought by recreational MDMA/Ecstasy users, which can inform treatment interventions and harm reduction policies.

The role of thought suppression in the relationship between mindfulness meditation and alcohol use.

Addictive behaviors October 1, 2007 Sarah Bowen, Katie Witkiewitz, Tiara M Dillworth et al.

Attempting to suppress thoughts about using substances can paradoxically increase substance use. Vipassana, a mindfulness meditation practice that emphasizes acceptance rather than suppression of unwanted thoughts, was previously shown to reduce substance use in incarcerated individuals. This follow-up study found that participants in a Vipassana course reported significantly less avoidance of thoughts compared to a control group receiving treatment as usual. This reduction in thought avoidance partially explained the course's positive effects on alcohol use and related consequences after release from incarceration.